# Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

> **NCT03511235** · — · COMPLETED · sponsor: **Myriad Genetic Laboratories, Inc.** · enrollment: 774 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03511235
- **Lead sponsor:** Myriad Genetic Laboratories, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-12
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 774 (ACTUAL)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03511235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03511235, "Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03511235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*